DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4 - PubMed (original) (raw)
doi: 10.1038/leu.2009.203. Epub 2009 Nov 12.
R Spinelli, S Bungaro, E Mangano, L Corral, I Cifola, G Fazio, M Giordan, G Basso, G De Rossi, A Biondi, C Battaglia, G Cazzaniga
Affiliations
- PMID: 19907438
- DOI: 10.1038/leu.2009.203
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4
M Bardini et al. Leukemia. 2010 Jan.
Abstract
The pathogenesis of infant acute lymphoblastic leukemia (ALL) is still not well defined. Short latency to leukemia and very high concordance rate for ALL in Mixed-Lineage Leukemia (MLL)-positive infant twins suggest that the MLL rearrangement itself could be sufficient for overt leukemia. Attempts to generate a suitable mouse model for MLL-AF4-positive ALL did not thoroughly resolve the issue of whether cooperating mutations are required to reduce latency and to generate overt leukemia in vivo. In this study, we applied single-nucleotide polymorphism array technology to perform genomic profiling of 28 infant ALL cases carrying t(4;11) to detect MLL-cooperating aberrations hidden to conventional techniques and to gain new insights into infant ALL pathogenesis. In contrast to pediatric, adolescent and adult ALL cases, the MLL rearrangement in infant ALL is associated with an exceptionally low frequency of copy-number abnormalities, thus confirming the unique nature of this disease. By contrast, additional genetic aberrations are acquired at disease relapse. Small-segmental uniparental disomy traits were frequently detected, mostly constitutional, and widely distributed throughout the genome. It can be argued that the MLL rearrangement as a first hit, rather than inducing the acquisition of additional genetic lesions, has a major role to drive and hasten the onset of leukemia.
Similar articles
- Molecular findings in childhood leukemia in Brazil: high frequency of MLL-ENL Fusion/t(11;19) in infant leukemia.
Marques EA, Neves L, Fonseca TC, Lins MM, Pedrosa F, Lucena-Silva N. Marques EA, et al. J Pediatr Hematol Oncol. 2011 Aug;33(6):470-4. doi: 10.1097/MPH.0b013e3181fb8f61. J Pediatr Hematol Oncol. 2011. PMID: 21436736 - The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia.
Dobbins SE, Sherborne AL, Ma YP, Bardini M, Biondi A, Cazzaniga G, Lloyd A, Chubb D, Greaves MF, Houlston RS. Dobbins SE, et al. Genes Chromosomes Cancer. 2013 Oct;52(10):954-60. doi: 10.1002/gcc.22090. Epub 2013 Jul 26. Genes Chromosomes Cancer. 2013. PMID: 23893660 - Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.
Bueno C, Montes R, Catalina P, Rodríguez R, Menendez P. Bueno C, et al. Leukemia. 2011 Mar;25(3):400-10. doi: 10.1038/leu.2010.284. Epub 2010 Dec 7. Leukemia. 2011. PMID: 21135858 Review. - A novel infant acute lymphoblastic leukemia cell line with MLL-AF5q31 fusion transcript.
Imamura T, Morimoto A, Ikushima S, Kakazu N, Hada S, Tabata Y, Yagi T, Inaba T, Hibi S, Sugimoto T, Imashuku S. Imamura T, et al. Leukemia. 2002 Nov;16(11):2302-8. doi: 10.1038/sj.leu.2402665. Leukemia. 2002. PMID: 12399976 - Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.
Chowdhury T, Brady HJ. Chowdhury T, et al. Blood Cells Mol Dis. 2008 Mar-Apr;40(2):192-9. doi: 10.1016/j.bcmd.2007.07.005. Epub 2007 Oct 1. Blood Cells Mol Dis. 2008. PMID: 17905612 Review.
Cited by
- Molecular processes involved in B cell acute lymphoblastic leukaemia.
Malouf C, Ottersbach K. Malouf C, et al. Cell Mol Life Sci. 2018 Feb;75(3):417-446. doi: 10.1007/s00018-017-2620-z. Epub 2017 Aug 17. Cell Mol Life Sci. 2018. PMID: 28819864 Free PMC article. Review. - Molecular characterization of identical, novel MLL-EPS15 translocation and individual genomic copy number alterations in monozygotic infant twins with acute lymphoblastic leukemia.
Kotecha RS, Ford J, Beesley AH, Anderson D, Cole CH, Kees UR. Kotecha RS, et al. Haematologica. 2012 Sep;97(9):1447-50. doi: 10.3324/haematol.2012.065730. Epub 2012 May 11. Haematologica. 2012. PMID: 22581003 Free PMC article. No abstract available. - Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemia.
EFSA Panel on Plant Protection Products and their residues (PPR); Ockleford C, Adriaanse P, Berny P, Brock T, Duquesne S, Grilli S, Hernandez-Jerez AF, Bennekou SH, Klein M, Kuhl T, Laskowski R, Machera K, Pelkonen O, Pieper S, Smith R, Stemmer M, Sundh I, Teodorovic I, Tiktak A, Topping CJ, Wolterink G, Angeli K, Fritsche E, Hernandez-Jerez AF, Leist M, Mantovani A, Menendez P, Pelkonen O, Price A, Viviani B, Chiusolo A, Ruffo F, Terron A, Bennekou SH. EFSA Panel on Plant Protection Products and their residues (PPR), et al. EFSA J. 2017 Mar 16;15(3):e04691. doi: 10.2903/j.efsa.2017.4691. eCollection 2017 Mar. EFSA J. 2017. PMID: 32625422 Free PMC article. - Secondary mutations in t(4;11) leukemia patients.
Prelle C, Bursen A, Dingermann T, Marschalek R. Prelle C, et al. Leukemia. 2013 Jun;27(6):1425-7. doi: 10.1038/leu.2012.365. Epub 2012 Dec 14. Leukemia. 2013. PMID: 23242105 Free PMC article. No abstract available. - High Expression of BCL11A Predicts Poor Prognosis for Childhood _MLL_-r ALL.
Wang LL, Yan D, Tang X, Zhang M, Liu S, Wang Y, Zhang M, Zhou G, Li T, Jiang F, Chen X, Wen F, Liu S, Mai H. Wang LL, et al. Front Oncol. 2021 Dec 6;11:755188. doi: 10.3389/fonc.2021.755188. eCollection 2021. Front Oncol. 2021. PMID: 34938655 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources